Adherence to controller therapy for chronic obstructive pulmonary disease: A review

Current Medical Research and Opinion

Volumn 26, Issue 10, 2010, Pages 2421-2429

  Charles, Meaghan St ^a   Blanchette, Christopher M ^a,b   Silver, Harris ^a   Lavallee, Danielle ^a   Dalal, Anand A ^c   Mapel, Douglas ^d  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b University of North Carolina   (United States)

^c GLAXOSMITHKLINE   (United States)

^d LOVELACE CLINIC FOUNDATION   (United States)

Author keywords

Controller therapy; COPD; Medication adherence; Review

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FORMOTEROL; IPRATROPIUM BROMIDE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TIOTROPIUM BROMIDE; TULOBUTEROL;

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMBINATION CHEMOTHERAPY; DRUG DOSE COMPARISON; DRUG FORMULATION; EMERGENCY CARE; EUROPEAN AMERICAN; GROUPS BY AGE; HEALTH CARE UTILIZATION; HOSPICE CARE; HUMAN; LENGTH OF STAY; MARRIAGE; MEDLINE; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; REVIEW; SYSTEMATIC REVIEW;

ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; HUMANS; MEDICATION ADHERENCE; PATIENT SATISFACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 77956729662     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.516284     Document Type: Review

References (24)

1. Hayes Jr D, Meyer KC. Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management. Drugs Aging 2007; 24:555-572
2. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002;51:1-16
3. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789
4. What are Anticholinergic Medications? New York, NY: American Thoracic Society, 2008. Available at: http://www.thoracic.org/clinical/copd-guidelines/ for-patients/what-kind-of-medications-are-there-for-copd/what-are- anticholinergic-medications.php [Last accessed 4 August 2010]
5. Delea T, Hagiwara M, Dalal A, et al. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/ salmeterol versus other inhaled maintenance therapies. Curr Med Res Opin 2009;25:1-13
6. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: Global Initiative for Chronic Obstructive Lung Disease, 2009
7. Julius RJ, Novitsky Jr MA, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract 2009; 15:34-44
8. Nietert PJ, Tilley BC, Zhao W, et al. Two pharmacy interventions to improve refill persistence for chronic disease medications: a randomized, controlled trial. Med Care 2009;47:32-40
9. Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences. Chest 2000;117(2 Suppl.):33S-7S
10. Sikka R, Xia F, Aubert R. Estimating medication persistency using administrative claims data. Am J Manag Care 2005;11:449-457
11. Van Grunsven P, Van Schayck C, Van Deuveren M, et al. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma 2000;37:225-234
12. Tamura G, Ohta K. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch. Respir Med 2007;101:1895-1902
13. Vestbo J, Anderson J, Calverly P, et al. Adherence to inhaled therapy, mortality, and hospital admission in COPD. Thorax 2009;64:939-943
14. Bender B, Pedan A, Varasteh L. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 2006; 118:899-904
15. Jung E, Pickard A, Salmon J, et al. Medication adherence and persistence in the last year of life in COPD patients. Respir Med 2009;103: 525-534
16. Krigsman K, Nilsson J, Ring L. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf 2007;16:441-448
17. Cramer J, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 2007;14:25-29
18. Breekveldt-Postma N, Koerselman J, Erkens J, et al. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med 2007;101:1398-1405
19. Akazawa M, Hayflinger D, Stanford R, et al. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. Am J Manag Care 2008;14:438-448
20. Sugawara T, Nanjo Y, Yamazaki M, et al. Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly patients with chronic obstructive pulmonary disorder. J Am Geriatr Soc 2009;57:919-920
21. Jones R, Hyland M, Hanney K, et al. A qualitative study of compliance with medication and lifestyle modification in Chronic Obstructive Pulmonary Disease (COPD). Prim Care Respir J 2004;13:149-154
22. Dolce J, Crisp C, Manzella B, et al. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991;99:837-841
23. Newman S. Inhaler treatment options in COPD. Eur Respir Rev 2005;14: 102-108
24. Restrepo R, Alvarez M, Wittnebel L, et al. Medication adherence issues in patients treated for COPD. Int J COPD 2008;3:371-384